Refuge Biotechnologies
A discovery-stage therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD136—205m (Dealroom.co estimates May 2018.)
Menlo Park California (HQ)
Authorizing premium user...